vs
合众银行（OSBC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$93.8M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 27.3%，领先356.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 15.1%）
合众银行是一家总部位于美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押等金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
OSBC vs RIGL — 直观对比
营收规模更大
OSBC
是对方的1.3倍
$69.8M
净利率更高
RIGL
高出356.8%
27.3%
两年增速更快
RIGL
近两年复合增速
15.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $93.8M | $69.8M |
| 净利润 | $25.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 27.3% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 159.2% | 1769.2% |
| 每股收益（稀释后） | $0.48 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OSBCRIGL
| Q1 26 | $93.8M | — | ||
| Q4 25 | $95.2M | $69.8M | ||
| Q3 25 | $95.9M | $69.5M | ||
| Q2 25 | $75.1M | $101.7M | ||
| Q1 25 | $73.1M | $53.3M | ||
| Q4 24 | $73.2M | $57.6M | ||
| Q3 24 | $71.2M | $55.3M | ||
| Q2 24 | $70.8M | $36.8M |
净利润OSBCRIGL
| Q1 26 | $25.6M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $9.9M | $27.9M | ||
| Q2 25 | $21.8M | $59.6M | ||
| Q1 25 | $19.8M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $23.0M | $12.4M | ||
| Q2 24 | $21.9M | $-1.0M |
毛利率OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 41.2% | 33.2% | ||
| Q3 25 | 13.6% | 40.9% | ||
| Q2 25 | 38.9% | 60.1% | ||
| Q1 25 | 35.8% | 23.9% | ||
| Q4 24 | 34.7% | 28.9% | ||
| Q3 24 | 41.9% | 25.4% | ||
| Q2 24 | 41.2% | 1.2% |
净利率OSBCRIGL
| Q1 26 | 27.3% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | 10.3% | 40.2% | ||
| Q2 25 | 29.0% | 58.6% | ||
| Q1 25 | 27.1% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 32.3% | 22.5% | ||
| Q2 24 | 30.9% | -2.8% |
每股收益（稀释后）OSBCRIGL
| Q1 26 | $0.48 | — | ||
| Q4 25 | $0.53 | $14.11 | ||
| Q3 25 | $0.18 | $1.46 | ||
| Q2 25 | $0.48 | $3.28 | ||
| Q1 25 | $0.43 | $0.63 | ||
| Q4 24 | $0.42 | $0.82 | ||
| Q3 24 | $0.50 | $0.70 | ||
| Q2 24 | $0.48 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $893.3M | $391.5M |
| 总资产 | $6.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资OSBCRIGL
| Q1 26 | $115.7M | — | ||
| Q4 25 | $124.0M | $155.0M | ||
| Q3 25 | $116.5M | $137.1M | ||
| Q2 25 | $141.8M | $108.4M | ||
| Q1 25 | $256.1M | $77.1M | ||
| Q4 24 | $99.3M | $77.3M | ||
| Q3 24 | $115.8M | $61.1M | ||
| Q2 24 | $120.9M | $49.1M |
总债务OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益OSBCRIGL
| Q1 26 | $893.3M | — | ||
| Q4 25 | $896.8M | $391.5M | ||
| Q3 25 | $866.7M | $117.6M | ||
| Q2 25 | $718.6M | $81.9M | ||
| Q1 25 | $694.5M | $18.6M | ||
| Q4 24 | $671.0M | $3.3M | ||
| Q3 24 | $661.4M | $-14.6M | ||
| Q2 24 | $619.3M | $-29.9M |
总资产OSBCRIGL
| Q1 26 | $6.8B | — | ||
| Q4 25 | $6.9B | $513.6M | ||
| Q3 25 | $7.0B | $242.5M | ||
| Q2 25 | $5.7B | $206.7M | ||
| Q1 25 | $5.7B | $176.0M | ||
| Q4 24 | $5.6B | $164.0M | ||
| Q3 24 | $5.7B | $139.4M | ||
| Q2 24 | $5.7B | $128.4M |
负债/权益比OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | $122.3M | $22.0M | ||
| Q3 25 | $35.9M | $24.0M | ||
| Q2 25 | $24.2M | $30.5M | ||
| Q1 25 | $17.8M | $-893.0K | ||
| Q4 24 | $131.5M | $14.5M | ||
| Q3 24 | $48.5M | $21.7M | ||
| Q2 24 | $11.6M | $302.0K |
自由现金流OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | $117.8M | — | ||
| Q3 25 | $34.7M | — | ||
| Q2 25 | $23.5M | — | ||
| Q1 25 | $16.2M | — | ||
| Q4 24 | $120.7M | — | ||
| Q3 24 | $46.2M | — | ||
| Q2 24 | $8.7M | — |
自由现金流率OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 123.7% | — | ||
| Q3 25 | 36.2% | — | ||
| Q2 25 | 31.2% | — | ||
| Q1 25 | 22.2% | — | ||
| Q4 24 | 165.0% | — | ||
| Q3 24 | 64.9% | — | ||
| Q2 24 | 12.3% | — |
资本支出强度OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 4.7% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 4.2% | — |
现金转化率OSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | 3.64× | 0.86× | ||
| Q2 25 | 1.11× | 0.51× | ||
| Q1 25 | 0.90× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.11× | 1.75× | ||
| Q2 24 | 0.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OSBC
| Net Interest Income | $81.1M | 87% |
| Noninterest Income | $12.6M | 13% |
RIGL
暂无分部数据
